Silencing of SCEL promotes progression of oral squamous cell carcinoma via activating TGF-β/Smad pathway.

Discov Oncol · 2025 · PMC12081798 · PMID 40372539

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In SAS cells, the G1 phase cell proportion in the SCEL overexpression group decreased by 18.48%, and the S phase cell proportion increased by 15.4% (both P < 0.05); the G2 phase cell proportion increased by 3.08%, showing an increasing trend without significant difference.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.